Variability and treatment of high on-prasugrel platelet reactivity in patients with initial high on-clopidogrel platelet reactivity

International Journal of Cardiology

Volumn 154, Issue 3, 2012, Pages 333-334

  Alexopoulos, Dimitrios ^a   Plakomyti, Theodora Eleni ^a   Xanthopoulou, Ioanna ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Antiplatelets; High on treatment platelet reactivity; Prasugrel

Indexed keywords

CLOPIDOGREL; PRASUGREL;

BLOOD CLOTTING PARAMETERS; BLOOD VESSEL REACTIVITY; DRUG EFFICACY; HIGH ON TREATMENT PLATELET REACTIVITY; HUMAN; LETTER; LOADING DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTE AGGREGATION; TREATMENT DURATION;

EID: 84855922081     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.10.031     Document Type: Article

References (9)

1. G. Campo, G. Parrinello, and P. Ferraresi Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome J Am Coll Cardiol 57 2011 2474 2483
2. A.D. Michelson, A.L. Frelinger III, and E. Braunwald TRITON-TIMI 38 Investigators. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial Eur Heart J 30 2009 1753 1763
3. L. Bonello, M. Pansieri, and J. Mancini High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes J Am Coll Cardiol 58 2011 467 473
4. H. Neubauer, A. Kaiser, B. Busse, and A. Mugge Identification, evaluation and treatment of prasugrel low-response after coronary stent implantation-a preliminary study Thromb Res 126 2010 e389 e391
5. D. Alexopoulos Prasugrel resistance: Fact or fiction Platelets Jul25 2011 [Epub ahead of print]
6. D. Alexopoulos, G. Dimitropoulos, and P. Davlouros Prasugrel overcomes high on-clopidogrel platelet reactivity post stenting more effectively than high dose (150 mg) clopidogrel: The importance of CYP2C19*2 genotyping J Am Coll Cardiol Int 4 2011 403 410
7. D. Alexopoulos, I. Xanthopoulou, and P. Davlouros Prasugrel overcomes high on-clopidogrel platelet reactivity in chronic coronary artery disease patients more effectively than high dose (150 mg) clopidogrel Am Heart J 162 2011 733 739
8. D. Alexopoulos, A. Panagiotou, and I. Xanthopoulou Antiplatelet effects of prasugrel vs double clopidogrel in patients on hemodialysis and high on-treatment platelet reactivity J Thromb Haemost 2011 [Oct 11, Electronic publication ahead of print]. doi: 10.1111/j.1538-7836.2011.04531.x
9. P.A. Gurbel, K.P. Bliden, and K. Butler Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study Circulation 121 2010 1188 1199